We are live on ! Find out more
SSA

Schonfeld Strategic Advisors Portfolio holdings

AUM $14.2B
1-Year Est. Return 37.17%
This Fund
S&P 500
This Quarter Est. Return
-0.8%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.74%
5 Year Est. Return
+136.38%
10 Year Est. Return
+1,412.31%
AUM
$11.9B
AUM Growth
+$1.64B
Cap. Flow
+$3.17B
Cap. Flow %
26.56%
Top 10 Hldgs %
6.6%
Holding
3,409
New
939
Increased
912
Reduced
776
Closed
491

Sector Composition

Rank Sector Weight
1 Financials 22.64%
2 Technology 16.18%
3 Consumer Discretionary 11.16%
4 Industrials 10.33%
5 Healthcare 8.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MEDP icon
1001
Medpace
MEDP
$16.3B
$1.55M 0.01%
+9,871
New +$1.58M
GOSS icon
1002
Gossamer Bio
GOSS
$87.5M
$1.55M 0.01%
129,344
+91,568
+242% +$1.14M
STM icon
1003
STMicroelectronics
STM
$49.6B
$1.54M 0.01%
49,861
-56,339
-53% -$1.98M
NET icon
1004
Cloudflare
NET
$106B
$1.54M 0.01%
27,842
+1,733
+7% +$103K
ABOS icon
1005
Acumen Pharmaceuticals
ABOS
$170M
$1.53M 0.01%
152,429
+36,400
+31% +$209K
MODV
1006
DELISTED
ModivCare
MODV
$1.53M 0.01%
+15,330
New +$1.59M
VAQC
1007
DELISTED
Vector Acquisition Corporation II Class A Ordinary Shares
VAQC
$1.53M 0.01%
154,042
+2,400
+2% +$23.6K
GRBK icon
1008
Green Brick Partners
GRBK
$3.14B
$1.52M 0.01%
+71,300
New +$1.76M
STWD icon
1009
Starwood Property Trust
STWD
$6.06B
$1.52M 0.01%
83,558
+70,058
+519% +$1.59M
HAE icon
1010
Haemonetics
HAE
$3.92B
$1.52M 0.01%
+20,500
New +$1.47M
EXPO icon
1011
Exponent
EXPO
$3.24B
$1.52M 0.01%
17,300
+5,700
+49% +$540K
IRWD icon
1012
Ironwood Pharmaceuticals
IRWD
$709M
$1.52M 0.01%
+146,563
New +$1.66M
KNTK icon
1013
Kinetik
KNTK
$3.63B
$1.51M 0.01%
46,500
+28,700
+161% +$1.06M
ELIQ
1014
DELISTED
Electriq Power Holdings, Inc.
ELIQ
$1.51M 0.01%
153,587
+58,837
+62% +$579K
CBRL icon
1015
Cracker Barrel
CBRL
$1.3B
$1.51M 0.01%
16,350
-7,311
-31% -$735K
PRI icon
1016
Primerica
PRI
$10B
$1.51M 0.01%
12,237
+5,337
+77% +$677K
COHR icon
1017
Coherent
COHR
$73.7B
$1.51M 0.01%
43,278
-47,054
-52% -$2.25M
TFIN icon
1018
Triumph Financial Inc
TFIN
$1.81B
$1.51M 0.01%
+27,721
New +$1.82M
DOX icon
1019
Amdocs
DOX
$6.21B
$1.51M 0.01%
+18,959
New +$1.61M
PII icon
1020
Polaris
PII
$4.06B
$1.5M 0.01%
15,700
+1,681
+12% +$188K
ARWR icon
1021
Arrowhead Research
ARWR
$12.3B
$1.5M 0.01%
45,422
+35,061
+338% +$1.41M
KN icon
1022
Knowles
KN
$3.32B
$1.5M 0.01%
+123,300
New +$1.98M
MTDR icon
1023
Matador Resources
MTDR
$6.12B
$1.5M 0.01%
30,600
+14,890
+95% +$804K
AVY icon
1024
Avery Dennison
AVY
$13.4B
$1.5M 0.01%
+9,200
New +$1.67M
ITCI
1025
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$1.49M 0.01%
32,071
-31,130
-49% -$1.63M

Similar funds

Schonfeld Strategic Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, Schonfeld Strategic Advisors held 3,409 positions worth $11.9B, up 16% from $10.3B the previous quarter. Its ten largest holdings account for 6.6% of the portfolio.

Schonfeld Strategic Advisors deployed $3.17B of net new capital in Q3 2022, opening 939 new positions and adding to 912 existing holdings. Its largest new stake was Corebridge Financial: 3,204,461 shares worth $63.1M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, down from 25% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Gen Digital, an estimated $94.3M trimmed.

  • Schonfeld Strategic Advisors's largest Q3 2022 buy was Corebridge Financial: 3,204,461 shares worth $63.1M.
  • Schonfeld Strategic Advisors added most to Fidelity National Information Services in Q3 2022, an estimated $94M increase.
  • Schonfeld Strategic Advisors's biggest Q3 2022 reduction was Gen Digital, cutting an estimated $94.3M.
  • Schonfeld Strategic Advisors fully exited UMB Financial in Q3 2022, selling an estimated $33.6M.
  • Schonfeld Strategic Advisors's ten largest holdings make up 6.6% of its $11.9B portfolio in Q3 2022.
  • Schonfeld Strategic Advisors opened 939 new positions and closed 491 in Q3 2022.
  • Schonfeld Strategic Advisors's portfolio value rose 16% quarter-over-quarter to $11.9B.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.